BioFactura and CuraTeQ Enter Exclusive License Agreement to Commercialize Biosimilar for Stelara July 10, 2023 BioFactura, Inc. and CuraTeQ Biologics Private Limited, a subsidiary of Aurobindo Pharma Limited, have signed [….]
Bowers R&D Associates is thrilled to announce that it is now offering R&D tax credit calculation services nationwide. Client Relationship Manager Laura Berry and Sales Administrator Marsha Cook are eager to meet with clients across the country to help them get the R&D credits they deserve.
Theradaptive Receives MSCRF Manufacturing Assistance Grant to Help Establish New cGMP Facility in Frederick
Cartesian Therapeutics, a clinical-stage biotechnology company pioneering cell therapies for autoimmune diseases, announced today the publication of a landmark paper in The Lancet Neurology. The study describes Descartes-08, a cutting-edge RNA CAR-T (rCAR-T) therapy administered to patients with generalized myasthenia gravis (MG), a debilitating autoimmune neurological disease. The data demonstrate marked and long-lasting clinical improvement in patients with MG. This is the first clinical trial using rCAR-T to treat autoimmunity, and the first successful Phase 2 trial using an engineered cell therapy to treat autoimmunity.
Cornell University Launches Flagship Biotech, Pharma Management Summit Ithaca, NY – June 5, 2023 – The Jeb E. Brooks School of Public Policy at Cornell University recently announced the launch [….]
